India Polymerase Chain Reaction (PCR) Devices Market By Type (Quantitative PCR, Digital PCR), By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Polymerase Chain Reaction (PCR) Devices Market in was valued at USD 271.06 Million in 2024 and is expected to reach USD 390.11 Million by 2030 with a CAGR of 6.37% during the forecast period.

The India Polymerase Chain Reaction (PCR) Devices Market has seen significant growth in recent years, driven by advancements in molecular diagnostics and increasing applications across clinical diagnostics, research, forensic science, and biotechnology. PCR devices are pivotal in amplifying DNA sequences, making them essential tools in detecting genetic mutations, identifying infectious diseases, and conducting genetic research. One of the primary drivers of market growth is the rising prevalence of infectious diseases such as COVID-19, tuberculosis, and HIV. For instance, According to a report by the World Health Organization (WHO), India recorded the second-highest number of hepatitis B and C cases in 2022, following China, with an estimated 35 million infections. The demand for accurate, rapid diagnostic methods has surged, driving the adoption of PCR devices in healthcare settings. The Indian government's initiatives to strengthen healthcare infrastructure and increase funding for research and development have further fueled market expansion.

Technological advancements in PCR devices, such as the development of real-time PCR (qPCR) and digital PCR, have enhanced the sensitivity, specificity, and throughput of these instruments. These innovations have broadened the scope of PCR applications, facilitating more precise and comprehensive genetic analyses. The integration of automated systems and user-friendly interfaces has also improved operational efficiency and reduced the turnaround time for diagnostic results.

The market is characterized by several key players, including multinational corporations and domestic companies, competing to offer advanced PCR solutions. Companies are focusing on strategic collaborations, mergers, and acquisitions to strengthen their market position and expand their product portfolios. The growing awareness about personalized medicine and the increasing demand for genetic testing are expected to provide lucrative opportunities for market players. Despite the positive growth trajectory, challenges such as the high cost of PCR devices and the need for skilled personnel to operate them may hinder market growth. However, ongoing efforts to develop cost-effective solutions and training programs for healthcare professionals are likely to mitigate these challenges, ensuring sustained market development.

Key Market Drivers

Increasing Prevalence of Infectious Diseases

The India Polymerase Chain Reaction devices market is being propelled by sustained diagnostic demand from infectious diseases and the scaling of molecular testing capacity across public and private healthcare settings. For instance, the Government of India reports record tuberculosis case notifications of 25.5 lakh in 2023 and 26.07 lakh in 2024, and the India TB Report 2024 highlights 63,939 multidrug-resistant TB cases diagnosed, underscoring why rapid molecular platforms are increasingly embedded in routine TB detection and drug-resistance screening. Seasonal and outbreak-prone vector-borne diseases further reinforce the need for rapid, accurate testing, with the National Centre for Vector Borne Diseases Control reporting 2,89,235 dengue cases and 485 deaths in 2023 and 2,33,519 cases and 297 deaths in 2024. In parallel, malaria surveillance and elimination efforts continue to require reliable diagnostics, with the Ministry of Health and Family Welfare reporting 2,27,564 malaria cases and 83 deaths in 2023. The COVID-19 experience also expanded India’s molecular diagnostics backbone, with the ICMR COVID testing portal showing 9,548 labs and 25,319 collection centres as of May 27, 2024, supporting ongoing PCR device adoption through wider lab networks, higher-throughput workflows, and public health testing programs.

Technological Advancements and Innovations

Technological advancements and innovations in PCR are major drivers of the India Polymerase Chain Reaction (PCR) devices market. Over the years, PCR technology has evolved significantly, leading to the development of more sophisticated and efficient devices. Innovations such as real-time PCR (qPCR), digital PCR (dPCR), and next-generation sequencing (NGS)-based PCR have revolutionized molecular diagnostics. These advanced PCR techniques offer higher sensitivity, specificity, and speed, enabling more accurate and timely results. Real-time PCR, for instance, enables quantification of DNA or RNA in real time, providing critical data for clinical diagnostics and research applications. This technique's ability to monitor amplification in real time has greatly improved the accuracy and reliability of molecular diagnostics. Digital PCR, on the other hand, partitions the sample into thousands of tiny droplets, enabling absolute quantification of nucleic acids and the detection of rare genetic mutations with unprecedented precision. NGS-based PCR integrates the benefits of sequencing with PCR's amplification capability, opening new avenues in genomics and personalized medicine.

The introduction of automated PCR systems has also streamlined laboratory workflows, reducing human error and increasing throughput. These systems automate the entire PCR process, from sample preparation to data analysis, ensuring consistent and reproducible results. The integration of advanced software and robotics in these systems further enhances their efficiency and accuracy, making them indispensable tools in high-throughput laboratories. The miniaturization of PCR devices and the development of portable, point-of-care PCR systems have expanded their applications beyond traditional laboratory settings. Portable PCR devices are particularly valuable in resource-limited and remote areas, where access to centralized laboratories is challenging. These compact devices provide rapid, on-site diagnostics, which is crucial for timely disease management and outbreak control.

Continuous investment in research and development by key market players fuels innovation in PCR technology. Companies are focused on developing next-generation PCR devices that are more user-friendly, faster, and capable of multiplexing—simultaneously detecting multiple targets in a single run. Such advancements enhance the versatility and utility of PCR technology across various applications, from clinical diagnostics and infectious disease detection to cancer research and genetic testing.

Growing Applications in Oncology

The growing applications of PCR technology in oncology are significantly contributing to the expansion of the India Polymerase Chain Reaction (PCR) devices market. Cancer diagnosis and treatment have seen remarkable advances through the integration of molecular diagnostics, with PCR playing a pivotal role. PCR technology is used in various aspects of oncology, including early detection, prognosis, monitoring treatment response, and identifying genetic mutations associated with different types of cancer. The ability of PCR to amplify and detect specific genetic sequences enables precise identification of cancer biomarkers, aiding early diagnosis of cancers such as breast, lung, and colorectal cancers. Early detection is crucial in cancer treatment, as it significantly increases the chances of successful intervention and improves patient outcomes. PCR’s high sensitivity and specificity make it an invaluable tool in identifying cancer at its nascent stages, often before symptoms manifest. This early diagnostic capability helps in initiating timely treatment, potentially saving lives.

PCR-based liquid biopsy techniques enable the detection of circulating tumor DNA (ctDNA) in blood samples, providing a non-invasive approach for cancer diagnosis and monitoring. Liquid biopsies offer a less invasive alternative to traditional tissue biopsies, reducing the discomfort and risk associated with surgical procedures. These techniques enable continuous monitoring of cancer progression and treatment efficacy, allowing oncologists to make informed decisions and adjust therapies as needed. The ability to detect minimal residual disease and emerging resistance mutations through liquid biopsies also helps tailor personalized treatment plans and improve patient management.

The increasing prevalence of cancer in India and the growing awareness about the importance of early diagnosis have led to a higher demand for PCR devices in oncology applications. The rising incidence of cancer, driven by factors such as aging population, lifestyle changes, and environmental influences, underscores the need for advanced diagnostic tools. As public and private healthcare sectors focus on improving cancer care, the adoption of PCR technology in oncology is expected to rise. Personalized medicine, which tailors treatment plans based on individual genetic profiles, relies heavily on PCR technology for genetic analysis. PCR enables the identification of genetic mutations and alterations that drive cancer, guiding the selection of targeted therapies and immunotherapies. This personalized approach enhances treatment efficacy and minimizes adverse effects, contributing to better patient outcomes.

Download Free Sample Report

Key Market Challenges

High Cost of PCR Devices and Consumables

One of the primary challenges in the India Polymerase Chain Reaction (PCR) devices market is the high cost associated with PCR machines and related consumables, such as reagents, primers, and kits. The initial investment required to purchase PCR machines can be substantial, often exceeding the budgetary capacity of many healthcare facilities. This financial barrier is particularly pronounced in rural and semi-urban areas, where healthcare infrastructure is often underdeveloped, and resources are limited. In these settings, accurate, timely diagnostic tools are critical for effective disease management, yet the high costs of PCR technology can severely limit access to these essential services.

The expensive nature of PCR technology not only affects larger hospitals but also deters smaller laboratories and clinics from adopting these advanced diagnostic devices. Many of these facilities operate on tight budgets and may prioritize essential services over costly investments in molecular diagnostics. This reluctance to invest in PCR technology leads to significant disparities in healthcare access across different regions. While urban areas may have access to cutting-edge diagnostic tools, rural regions often rely on outdated methods that lack the precision and reliability of PCR testing.

The costs associated with consumables can accumulate over time, making ongoing operations financially burdensome for facilities that do choose to implement PCR testing. Reagents, primers, and kits often have expiration dates and require regular replenishment, which adds to overall costs.

Technical Complexity and Training Requirements

PCR technology, despite its effectiveness, is complex and requires skilled personnel for proper execution and interpretation of results. This technical complexity poses a significant challenge for the Polymerase Chain Reaction (PCR) devices market in India, particularly in a healthcare landscape where resources and expertise may be limited. The successful implementation of PCR testing requires not only a thorough understanding of the principles of molecular biology but also proficiency with sophisticated laboratory equipment.

In India, there is often a shortage of qualified technicians proficient in advanced molecular techniques, which can lead to variations in testing quality and reliability. Insufficient training for laboratory personnel can lead to inconsistent results and errors, undermining the credibility of PCR testing. When technicians are not adequately trained, the risk of contamination, sample mishandling, and misinterpretation of results increases, making it harder to diagnose and manage diseases effectively. Consequently, this can erode healthcare providers' confidence in PCR testing, which may deter them from fully integrating this valuable technology into their practices. To address this issue, it is crucial to develop robust training initiatives that equip laboratory personnel with the necessary skills to operate PCR devices effectively. Implementing comprehensive training programs that combine theoretical knowledge with hands-on experience can help bridge the skills gap in the workforce. Collaboration between academic institutions, healthcare organizations, and industry stakeholders can facilitate the creation of standardized training curricula tailored to the needs of different laboratories.

Key Market Trends

Increasing Prevalence of Infectious Diseases

The India Polymerase Chain Reaction (PCR) devices market is experiencing substantial growth, driven primarily by the increasing prevalence of infectious diseases. In recent years, India has seen a surge in various infectious diseases such as tuberculosis, dengue, malaria, and more recently, the COVID-19 pandemic. These diseases require rapid, accurate diagnostic tools to manage and control outbreaks effectively. PCR devices, known for their precision in detecting pathogens at the genetic level, have become indispensable in diagnosing these infections. For instance, In March 2024, Co-Diagnostics, Inc., a molecular diagnostics company known for its unique patented platform for developing molecular diagnostic tests, announced that CoSara Diagnostics Pvt Ltd ("CoSara"), its joint venture for manufacturing and sales in India, has received clearance from the Central Drugs Standard Control Organization ("CDSCO") to manufacture and market its SARAPLEX Influenza Multiplex (IFM) Test Kit. This kit is intended for use by clinical laboratories as an in vitro diagnostic ("IVD") tool for the detection and differentiation of Influenza A and Influenza B. The heightened need for timely and reliable diagnostics has significantly boosted the demand for PCR devices in the country. Public health initiatives and government programs aimed at controlling infectious diseases further underscore the importance of PCR technology. These efforts include widespread testing campaigns, enhanced laboratory capabilities, and partnerships with private healthcare providers, all of which contribute to the growing adoption of PCR devices. The ability of PCR technology to detect low levels of pathogens even in asymptomatic individuals makes it a critical tool in breaking the chain of transmission and managing disease outbreaks.

The resurgence of tuberculosis (TB) has been particularly alarming in India, which accounts for a significant proportion of the global TB burden. The World Health Organization (WHO) has highlighted the importance of molecular diagnostics, including PCR, in TB detection and monitoring. PCR's ability to rapidly identify drug-resistant strains of TB has been a game-changer in tailoring appropriate treatments and reducing transmission rates. Similarly, vector-borne diseases such as dengue and malaria, which experience seasonal spikes, have underscored the need for rapid diagnostics to enable timely interventions and prevent severe outcomes.

The COVID-19 pandemic further amplified the role of PCR technology. The unprecedented need for mass testing to identify and isolate infected individuals placed PCR at the forefront of diagnostic efforts. The government’s push for widespread testing, coupled with the private sector’s ramp-up of PCR testing capabilities, has highlighted the scalability and reliability of PCR technology in managing large-scale health crises. As infectious diseases continue to pose significant health challenges in India, the demand for PCR devices is expected to remain robust, driving market growth. The integration of PCR technology in public health strategies and its proven efficacy in various disease scenarios make it a cornerstone in the ongoing battle against infectious diseases. This trend is likely to persist, ensuring that PCR devices remain a critical component of India's healthcare infrastructure.

Increasing Use in Genetic Testing

The increasing use of PCR technology in genetic testing is a major driver for the India Polymerase Chain Reaction (PCR) devices market. Genetic testing has become an integral part of modern healthcare, enabling the diagnosis of inherited disorders, the identification of genetic predispositions, and the guidance of reproductive planning. PCR technology is widely used in genetic testing because it can amplify and detect specific DNA sequences with high accuracy. It is employed in various applications, including carrier screening, prenatal testing, newborn screening, and pharmacogenomics. Carrier screening involves testing individuals to determine if they carry a gene for a specific genetic disorder. PCR technology enables precise detection of carrier status, helping prospective parents understand their risk of passing on genetic conditions to their offspring. Prenatal testing uses PCR to identify genetic abnormalities in a fetus, enabling early intervention and informed decision-making during pregnancy. Newborn screening, conducted shortly after birth to detect genetic disorders that can be treated early in life, relies on PCR for rapid, accurate results.

Pharmacogenomics, which studies how genes affect a person's response to drugs, utilizes PCR to analyze genetic variations that influence drug metabolism and efficacy. This information is crucial for personalizing medication regimens, ensuring that patients receive the most effective and safe treatments based on their genetic profiles. The growing awareness of the importance of genetic testing in disease prevention and management has led to increased demand for PCR devices. In India, genetic testing is gaining popularity as more people seek information about their genetic makeup and potential health risks. The increasing prevalence of genetic disorders, such as thalassemia, cystic fibrosis, and sickle cell anemia, underscores the need for comprehensive genetic testing solutions. The rising adoption of preventive healthcare measures, driven by increased health consciousness and advances in medical technology, is increasing demand for PCR-based genetic testing.

The development of advanced PCR techniques, such as multiplex PCR and quantitative PCR, has enhanced the efficiency and reliability of genetic tests. Multiplex PCR allows for the simultaneous detection of multiple genetic targets in a single reaction, reducing the time and cost associated with genetic testing. Quantitative PCR provides precise quantification of DNA or RNA, enabling detailed analysis of genetic variations and expression levels. As genetic testing becomes more accessible and affordable, the demand for PCR devices is expected to grow, driving the overall market. Government initiatives and policies aimed at promoting genetic testing and personalized medicine are also expected to boost the adoption of PCR technology. As a result, PCR devices will continue to play a critical role in advancing genetic testing, improving healthcare outcomes, and fostering a proactive approach to health and wellness. The integration of PCR technology into routine clinical practice will further solidify its importance in genetic testing, ensuring sustained growth in the India PCR devices market.

Segmental Insights

Type Insights

Based on the Type, In the India Polymerase Chain Reaction (PCR) devices market, quantitative PCR (qPCR) is currently dominating the type of segment. This dominance can be attributed to several key factors that highlight its advantages over digital PCR (dPCR) in clinical and research applications. qPCR is a robust, established method for quantifying nucleic acids, making it highly versatile for applications such as gene expression analysis, pathogen detection, and genetic variation studies. Its ability to provide real-time data during amplification enables researchers and clinicians to obtain rapid results, which is crucial in time-sensitive scenarios such as infectious disease diagnostics.

qPCR is more widely adopted because it is compatible with existing laboratory workflows and equipment. Many laboratories already use qPCR systems, making it easier for them to integrate this technology without significant additional investment in new infrastructure. The cost-effectiveness of qPCR contributes to its popularity. Compared to dPCR, which requires more specialized equipment and often incurs higher operational costs, qPCR devices are generally more affordable and accessible for a broader range of healthcare facilities and research institutions.

Download Free Sample Report

Regional Insights

In the India Polymerase Chain Reaction (PCR) devices market, the south India region dominated due to several key factors that drive its growth and adoption of molecular diagnostics. This region is home to some of the country’s leading healthcare institutions, research centers, and biotechnology companies, all of which significantly drive demand for advanced PCR technology. States such as Tamil Nadu, Karnataka, and Andhra Pradesh have established a strong healthcare infrastructure, with numerous diagnostic laboratories and hospitals that utilize PCR devices for various applications, including infectious disease detection and genetic testing. The presence of prominent research institutions and universities in southern India also fosters innovation and development in molecular biology, further bolstering the region's position in the PCR market.

The increasing prevalence of infectious diseases and genetic disorders in southern India has heightened the need for accurate and timely diagnostic solutions. Public health initiatives and government support for improving healthcare access and quality in this region have also played a crucial role in driving the adoption of PCR technology. The growing awareness among healthcare providers and patients about the benefits of molecular diagnostics has led to increased utilization of PCR testing services. As a result, the southern region continues to dominate the India PCR devices market, positioning itself as a hub for advanced diagnostics and healthcare solutions.

Recent Developments

• In November 2025, Co-Diagnostics announced it engaged Maxim Group to pursue a SPAC transaction for its Indian JV CoSara, including the possibility of a merger with a SPAC or similar listed entity.
• In July 2025, Avacta announced an agreement to sell Coris Bioconcept to India’s 3B BlackBio Dx for an upfront £2.15 million plus an earn-out of up to £0.615 million (subject to customary closing conditions), strengthening 3B BlackBio’s IVD portfolio relevant to molecular diagnostics workflows.
• In February 2023, Thermo Fisher Scientific announced the launch of its real-time PCR kits for detecting infectious diseases in India. The Applied Biosystems TaqPath PCR kits are specifically designed to ensure confidence and reliability in diagnostic development and testing. These kits target a range of infectious diseases, including Multi-Drug-Resistant Tuberculosis (MTB MDR), M. tuberculosis complex (MTB), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and genetic analysis (HLA B27). The Central Drugs Standard Control Organization (CDSCO) has granted licensing rights for these kits, which will be produced in India in collaboration with Mylab Discovery Solutions, a leading healthcare provider in the country. This partnership underscores Thermo Fisher Scientific’s commitment to enhancing diagnostic capabilities in India.

Key Market Players

• Thermo Fisher Scientific India Pvt. Ltd
• Bio - Rad Labroatories ( India ) Private Limited
• QIAGEN India Pvt. Ltd
• Cole-Parmer India
• Abbott India Ltd
• Molbio Diagnostics Pvt. Ltd.
• Roche Products (India) Pvt. Ltd.
• Becton Dickinson India Private ltd
• Agilent Technologies International Pvt Ltd

Report Scope:

In this report, the India Polymerase Chain Reaction (PCR) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Polymerase Chain Reaction (PCR) Devices Market, By Type:

o   Quantitative PCR

o   Digital PCR

• India Polymerase Chain Reaction (PCR) Devices Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Laboratories

o   Pharmaceutical & Biotechnology Companies

o   Others

• India Polymerase Chain Reaction (PCR) Devices Market, By Region:

o   North

o   South

o   West

o   East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Polymerase Chain Reaction (PCR) Devices Market.

Available Customizations:

India Polymerase Chain Reaction (PCR) Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Polymerase Chain Reaction (PCR) Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]